ATE205072T1 - Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung - Google Patents

Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung

Info

Publication number
ATE205072T1
ATE205072T1 AT98954562T AT98954562T ATE205072T1 AT E205072 T1 ATE205072 T1 AT E205072T1 AT 98954562 T AT98954562 T AT 98954562T AT 98954562 T AT98954562 T AT 98954562T AT E205072 T1 ATE205072 T1 AT E205072T1
Authority
AT
Austria
Prior art keywords
cosmetic composition
compound
indigotype
composition containing
radical
Prior art date
Application number
AT98954562T
Other languages
English (en)
Inventor
Michel Philippe
Jean-Christophe Henrion
Nathalie Guillier-Berteuil
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE205072T1 publication Critical patent/ATE205072T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
AT98954562T 1997-11-21 1998-11-12 Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung ATE205072T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714656A FR2771286B1 (fr) 1997-11-21 1997-11-21 Composition cosmetique comprenant un compose de type indigoide
PCT/FR1998/002411 WO1999026586A1 (fr) 1997-11-21 1998-11-12 Composition cosmetique comprenant un compose de type indigoide

Publications (1)

Publication Number Publication Date
ATE205072T1 true ATE205072T1 (de) 2001-09-15

Family

ID=9513655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954562T ATE205072T1 (de) 1997-11-21 1998-11-12 Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung

Country Status (10)

Country Link
US (1) US6406685B1 (de)
EP (1) EP1032353B1 (de)
JP (1) JP3572258B2 (de)
AT (1) ATE205072T1 (de)
AU (1) AU1162699A (de)
CA (1) CA2309296C (de)
DE (1) DE69801594T2 (de)
ES (1) ES2163301T3 (de)
FR (1) FR2771286B1 (de)
WO (1) WO1999026586A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787023A1 (fr) * 1998-12-11 2000-06-16 Oreal Utilisation d'un compose indigoide dans une composition cosmetique, notamment de maquillage, pour lui conferer des proprietes anti-microbiennes et de longue tenue.
FR2810881B1 (fr) * 2000-06-30 2004-03-26 Lcw Les Colorants Wackherr Composition de laque a usage cosmetique
FR2827506A1 (fr) * 2001-07-20 2003-01-24 Oreal Composition pulverulente et son utilisation en cosmetique
US20030219391A1 (en) * 2002-02-28 2003-11-27 L'oreal Dispersed powders providing ultraviolet light protection, suitable for use in cosmetic compositions
US7534453B1 (en) 2002-09-05 2009-05-19 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticles and use in enhancing cell survivability
US7959949B2 (en) 2006-04-27 2011-06-14 University Of Central Florida Research Foundation, Inc. Functionalized nanoceria composition for ophthalmic treatment
US9119391B1 (en) 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
AU2009240470B8 (en) * 2008-04-25 2015-02-05 The Board Of Regents Of The University Of Oklahoma Inhibition of neovascularization by cerium oxide nanoparticles
US8916199B1 (en) 2008-04-25 2014-12-23 University of Central Florida Research Foundation, Ind. Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
US9127202B1 (en) 2008-07-18 2015-09-08 University Of Central Florida Research Foundation, Inc. Biocompatible nano rare earth oxide upconverters for imaging and therapeutics
US8883519B1 (en) 2009-03-17 2014-11-11 University Of Central Florida Research Foundation, Inc. Oxidase activity of polymeric coated cerium oxide nanoparticles
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
FR2954120B1 (fr) * 2009-12-18 2012-02-24 Oreal Composition cosmetique comprenant un compose de type indigoide et un compose organique particuliers, et son utilisation en coloration.
JP2013503928A (ja) 2009-09-02 2013-02-04 ロレアル 疎水性染料、特定の無機アルカリ剤及び／又は有機アルカリ剤、特定の化合物（ｉ）及び特定の有機化合物（ｉｉ）を含む組成物、並びに染色におけるその使用
US8795731B1 (en) 2009-10-12 2014-08-05 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation
US8877207B2 (en) 2010-09-17 2014-11-04 University Of Central Florida Research Foundation, Inc. Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods
US8951539B1 (en) 2011-06-07 2015-02-10 University Of Central Florida Research Foundation, Inc. Methods of promoting angiogenesis using cerium oxide nanoparticles
US9161950B2 (en) 2011-09-21 2015-10-20 University Of Central Florida Foundation, Inc. Neuronal protection by cerium oxide nanoparticles
US9463437B2 (en) 2013-02-14 2016-10-11 University Of Central Florida Research Foundation, Inc. Methods for scavenging nitric oxide using cerium oxide nanoparticles
US9867761B2 (en) 2014-04-30 2018-01-16 L Star Softcoat, Llc Colored lamellar compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427888A1 (de) * 1994-08-08 1996-02-15 Linea Conception Software Gmbh Verfahren zum Färben von Haaren
EP0806199A3 (de) * 1996-05-09 2000-08-16 Wella Aktiengesellschaft Mittel und Verfahren zum Färben von Keratinfasern

Also Published As

Publication number Publication date
JP2001523697A (ja) 2001-11-27
EP1032353A1 (de) 2000-09-06
FR2771286A1 (fr) 1999-05-28
CA2309296C (fr) 2006-05-23
WO1999026586A1 (fr) 1999-06-03
AU1162699A (en) 1999-06-15
JP3572258B2 (ja) 2004-09-29
DE69801594T2 (de) 2002-07-11
ES2163301T3 (es) 2002-01-16
EP1032353B1 (de) 2001-09-05
US6406685B1 (en) 2002-06-18
DE69801594D1 (de) 2001-10-11
CA2309296A1 (fr) 1999-06-03
FR2771286B1 (fr) 1999-12-31

Similar Documents

Publication Publication Date Title
ATE205072T1 (de) Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
CA2079485A1 (en) Chelator compositions comprising oxime compounds
IL108562A (en) 7, 8-diaryl-1,2,3,4- terahydropyrazolo- £5,1-c| £1,2,4| triazine derivatives, methods for the preparation thereof and pharmaceutical compositions containing them
EP0420722A3 (en) Lipid compounds, derivatives of sphingosines, process for their preparation and their use, especially in cosmetics and in dermopharmaceutics
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
MY108076A (en) Cationic compound and cleaning composition.
ES2114645T3 (es) Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida.
HK81892A (en) Antimycotic nail varnish
MX9704449A (es) Compuestos de aminosilano en composiciones de caucho cargadas con silice.
AU3559193A (en) New 3',5'-di-tert-butyl-4'-hydroxy flavones, process for the preparation thereof and pharmaceutical compositions containing them
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
AU3793589A (en) New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics
BR9712221A (pt) Uso de pelo menos um 1,3-bis(n-lactamil) propano, composto, e, composições farmacêutica e cosmética.
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
MX9606315A (es) Composiciones de hule rellenas con silice, que contienen polisulfuros de dialquilenamida.
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
WO1998049998A3 (de) Verwendung von glykosidischen siliconverbindungen zur herstellung von kosmetischen und/oder pharmazeutischen zubereitungen
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
HK1033455A1 (en) Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
NO994107D0 (no) Preparater for behandling eller forhindring av prostatakreft
EP0296979A3 (en) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidine derivatives, their preparation, their use and preparations containing them
MY115907A (en) Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
ATE4720T1 (de) Neue derivate von cardenolid-bis-digitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee